Q4 2024 Earnings Conference Call March 31, 2025 4:30 PM ETCompany ParticipantsAdanna Alexander – IRPhillip Chan - ...
AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses ...
Several studies have reported that the coronavirus disease 2019 (COVID-19) can lead to heart rate variability (HRV), with the ...
Research from Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago strongly ...
Credit: Unsplash/ Kelly Sikkema. Acute flaccid myelitis (AFM) is a rare but serious neurological condition that impacts the ...
VQ Biomedical, a startup born at Duke University, has secured $5 million in funding to advance a device it says will treat ...
Five years after the first cases of COVID-19 appeared in the suburbs, Elgin Fire Department Division Chief Chris Kennedy ...
Key findings • Sarcoidosis patients are prone to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, increased severity, morbidity and greater mortality of coronavirus disease 2019 ...
Inhaled sevoflurane sedation in patients with moderate to severe acute respiratory distress syndrome results in fewer ...
Researchers uncover how probiotics and diet shape the gut microbiome to boost vaccine efficacy, offering new avenues for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback